TRUSOPTIDE dorzolamide (as hydrochloride) 20 mg/mL eye drops bottle
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
16-05-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
dorzolamide hydrochloride, Quantity: 22.26 mg/mL
Available from:
Arrotex Pharmaceuticals Pty Ltd
Pharmaceutical form:
Eye Drops, solution
Composition:
Excipient Ingredients: water for injections; mannitol; sodium hydroxide; benzalkonium chloride; hyetellose; sodium citrate dihydrate
Administration route:
Ophthalmic
Units in package:
5 mL
Prescription type:
(S4) Prescription Only Medicine
Therapeutic indications:
Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Product summary:
Visual Identification: Clear colourless slightly viscous solution.; Container Type: Bottle; Container Material: LDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Authorization status:
Registered
Authorization date:
2018-06-15
